Extracts from Clinicaltrials.gov database of clinical trials with listing of mutations as inclusion/exclusion criteria.
This could be used as a starting point to explore mutation-based treatments that were deemed worthy enough to start a clinical trial.
Updates:
22 Jul 2022: Added Results Links to some entries.
Added NCT02677038 trial of Olaparib for wild-type (not mutated) BRCA1/2 patients
(Visited 96 times, 1 visits today)